Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Notes underwriting agrmnt
Adamis Pharmaceuticals Corp (ADMP) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 8-K Quarterly results
Docs: "Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
05/15/2023 8-K Quarterly results
Docs: "Q1 2023 Corporate Highlights"
03/16/2023 8-K Quarterly results
Docs: "Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update"
11/14/2022 8-K Quarterly results
08/10/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
03/31/2022 8-K Quarterly results
Docs: "Adamis Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Corporate Update"
11/22/2021 8-K Quarterly results
Docs: "Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update"
04/15/2021 8-K Quarterly results
11/09/2020 8-K Quarterly results
Docs: "Adamis Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update"
08/17/2020 8-K Quarterly results
05/18/2020 8-K Quarterly results
Docs: "Adamis Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update"
03/30/2020 8-K Quarterly results
11/12/2019 8-K Quarterly results
08/08/2019 8-K Quarterly results
05/09/2019 8-K Quarterly results
Docs: "Adamis Pharmaceuticals Announces First Quarter 2019 Financial Results and Business Update"
11/14/2018 8-K Quarterly results
Docs: "Adamis Pharmaceuticals Announces Third Quarter 2018 Financial Results and Business Update"
08/10/2018 8-K Quarterly results
Docs: "Adamis Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Update"
11/16/2006 8-K Quarterly results
Docs: "Cellegy Reports September 30, 2006 Quarter Financial Results Quakertown, Pennsylvania - November 15, 2006 --Cellegy Pharmaceuticals, Inc. announced its third quarter 2006 financial results today. Revenues for the three months ended September 30, 2006 were $172,000 compared to $1,738,000 during the same period in 2005. Prior year revenues for the third quarter included $1,252,000 in Biosyn grant revenue, $257,000 in product sales and $109,000 in licensing revenues. Revenues for the nine months ended September 30, 2006 were $2,635,000 compared to $10,804,000 for the same period in 2005. These included licensing revenues of $452,000 and $6,950,000 for the nine months ended September 30, 2006 and 2005, respectively. Research and development expenses for the three months ended September 30, 200..."
03/31/2006 8-K Quarterly results
Docs: "CELLEGY PHARMACEUTICALS, INC. SUMMARY FINANCIAL RESULTS"
03/31/2005 8-K Quarterly results
Docs: "Cellegy Pharmaceuticals Reports 2004 Financial Results",
"BUSINESS UPDATE BY CELLEGY CHAIRMAN Brisbane, California, March 29, 2005 - Cellegy Pharmaceuticals, Inc. . In a conference call today regarding year-end 2004 results and developments at Cellegy Pharmaceuticals, Richard C. Williams, Chairman and interim CEO of the company, provided an update on progress made in several key areas. In a conference call in early January 2005 shortly after he assumed the position of interim CEO, Mr. Williams reported that the company would be striving to accomplish in 2005 several key elements of redirection under his leadership, and that the company would provide an update once accomplishments were realized. Key actions identified in January included:"
11/10/2004 8-K Quarterly results
Docs: "Cellegy Pharmaceuticals Reports Third Quarter Financial Results"
08/10/2004 8-K Quarterly results
Docs: "Cellegy Pharmaceuticals Reports Second Quarter Financial Results"
05/06/2004 8-K Quarterly results
Docs: "Registrant's Telephone Number, Including Area Code)",
"Cellegy Pharmaceuticals Reports First Quarter Financial Results"
03/25/2004 8-K Quarterly results
Docs: "Cellegy Pharmaceuticals Reports 2003 Financial Results"
11/06/2003 8-K Quarterly results
Docs: "Cellegy Pharmaceuticals Reports Third Quarter Financial Results"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy